Episode 76 - The Impact of Long-acting Injectable HIV Treatments on Public Health with Dr Kelly Gebo (May 5, 2026)

In episode 76 of Going anti-Viral, Dr Kelly Gebo joins host Dr Michael Saag to discuss the impact of long-acting injectable HIV treatments on public health. Dr Gebo is Dean of the Milken Institute School of Public Health at the George Washington University. An infectious disease physician-scientist, educator, and accomplished academic leader, Dr Gebo’s work focuses on health equity, access to care, and outcomes for people affected by infectious diseases such as HIV, COVID-19, and Mpox. Dr Gebo and Dr Saag discuss the current state of HIV epidemiology, the promise of long-acting injectables, and strategies to improve access and prevention efforts. Dr Saag and Dr Gebo also emphasize that advocacy is needed to expand access to long-acting injectable HIV treatments to reach at-risk populations.